225 related articles for article (PubMed ID: 37886644)
1.
Pihlström S; Richardt S; Määttä K; Pekkinen M; Olkkonen VM; Mäkitie O; Mäkitie RE
Front Endocrinol (Lausanne); 2023; 14():1224318. PubMed ID: 37886644
[TBL] [Abstract][Full Text] [Related]
2. Osteoporosis and skeletal dysplasia caused by pathogenic variants in SGMS2.
Pekkinen M; Terhal PA; Botto LD; Henning P; Mäkitie RE; Roschger P; Jain A; Kol M; Kjellberg MA; Paschalis EP; van Gassen K; Murray M; Bayrak-Toydemir P; Magnusson MK; Jans J; Kausar M; Carey JC; Somerharju P; Lerner UH; Olkkonen VM; Klaushofer K; Holthuis JC; Mäkitie O
JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30779713
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Genetic Characteristics of Calvarial Doughnut Lesions with Bone Fragility in Three Families with a Reccurent
Merkuryeva E; Markova T; Tyurin A; Valeeva D; Kenis V; Sumina M; Sorokin I; Shchagina O; Skoblov M; Nefedova M; Khusainova R; Zakharova E; Dadali E; Kutsev S
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175737
[TBL] [Abstract][Full Text] [Related]
4. Calvarial doughnut lesions with bone fragility in a French-Canadian family; case report and review of the literature.
Basalom S; Fiscaletti M; Miranda V; Huber C; Couture G; Drouin R; Monceau É; Wavrant S; Dubé J; Mäkitie O; Cormier-Daire V; Campeau PM
Bone Rep; 2021 Dec; 15():101121. PubMed ID: 34504906
[TBL] [Abstract][Full Text] [Related]
5. A Novel IFITM5 Variant Associated with Phenotype of Osteoporosis with Calvarial Doughnut Lesions: A Case Report.
Mäkitie RE; Pekkinen M; Morisada N; Kobayashi D; Yonezawa Y; Nishimura G; Ikegawa S; Mäkitie O
Calcif Tissue Int; 2021 Dec; 109(6):626-632. PubMed ID: 34156493
[TBL] [Abstract][Full Text] [Related]
6. Abnormal Bone Tissue Organization and Osteocyte Lacunocanalicular Network in Early-Onset Osteoporosis Due to
Mäkitie RE; Blouin S; Välimäki VV; Pihlström S; Määttä K; Pekkinen M; Fratzl-Zelman N; Mäkitie O; Hartmann MA
JBMR Plus; 2021 Nov; 5(11):e10537. PubMed ID: 34761145
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic variants of sphingomyelin synthase SMS2 disrupt lipid landscapes in the secretory pathway.
Sokoya T; Parolek J; Foged MM; Danylchuk DI; Bozan M; Sarkar B; Hilderink A; Philippi M; Botto LD; Terhal PA; Mäkitie O; Piehler J; Kim Y; Burd CG; Klymchenko AS; Maeda K; Holthuis JCM
Elife; 2022 Sep; 11():. PubMed ID: 36102623
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization.
Li Z; Hailemariam TK; Zhou H; Li Y; Duckworth DC; Peake DA; Zhang Y; Kuo MS; Cao G; Jiang XC
Biochim Biophys Acta; 2007 Sep; 1771(9):1186-94. PubMed ID: 17616479
[TBL] [Abstract][Full Text] [Related]
9. Musculoskeletal phenotype in two unrelated individuals with a recurrent nonsense variant in SGMS2.
Robinson ME; Bardai G; Veilleux LN; Glorieux FH; Rauch F
Bone; 2020 May; 134():115261. PubMed ID: 32028018
[TBL] [Abstract][Full Text] [Related]
10. Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in mice.
Liu J; Zhang H; Li Z; Hailemariam TK; Chakraborty M; Jiang K; Qiu D; Bui HH; Peake DA; Kuo MS; Wadgaonkar R; Cao G; Jiang XC
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):850-6. PubMed ID: 19286635
[TBL] [Abstract][Full Text] [Related]
11. Sphingomyelin synthase SMS2 displays dual activity as ceramide phosphoethanolamine synthase.
Ternes P; Brouwers JF; van den Dikkenberg J; Holthuis JC
J Lipid Res; 2009 Nov; 50(11):2270-7. PubMed ID: 19454763
[TBL] [Abstract][Full Text] [Related]
12. Both sphingomyelin synthases SMS1 and SMS2 are required for sphingomyelin homeostasis and growth in human HeLa cells.
Tafesse FG; Huitema K; Hermansson M; van der Poel S; van den Dikkenberg J; Uphoff A; Somerharju P; Holthuis JC
J Biol Chem; 2007 Jun; 282(24):17537-47. PubMed ID: 17449912
[TBL] [Abstract][Full Text] [Related]
13. Sphingomyelin synthase 2 promotes an aggressive breast cancer phenotype by disrupting the homoeostasis of ceramide and sphingomyelin.
Zheng K; Chen Z; Feng H; Chen Y; Zhang C; Yu J; Luo Y; Zhao L; Jiang X; Shi F
Cell Death Dis; 2019 Feb; 10(3):157. PubMed ID: 30770781
[TBL] [Abstract][Full Text] [Related]
14. Chlamydia trachomatis-infected human cells convert ceramide to sphingomyelin without sphingomyelin synthases 1 and 2.
Tachida Y; Kumagai K; Sakai S; Ando S; Yamaji T; Hanada K
FEBS Lett; 2020 Feb; 594(3):519-529. PubMed ID: 31596951
[TBL] [Abstract][Full Text] [Related]
15. Imaging Mass Spectrometry Reveals Acyl-Chain- and Region-Specific Sphingolipid Metabolism in the Kidneys of Sphingomyelin Synthase 2-Deficient Mice.
Sugimoto M; Wakabayashi M; Shimizu Y; Yoshioka T; Higashino K; Numata Y; Okuda T; Zhao S; Sakai S; Igarashi Y; Kuge Y
PLoS One; 2016; 11(3):e0152191. PubMed ID: 27010944
[TBL] [Abstract][Full Text] [Related]
16. Differential localization of sphingomyelin synthase isoforms in neurons regulates sphingomyelin cluster formation.
Kidani Y; Ohshima K; Sakai H; Kohno T; Baba A; Hattori M
Biochem Biophys Res Commun; 2012 Jan; 417(3):1014-7. PubMed ID: 22209789
[TBL] [Abstract][Full Text] [Related]
17. Early-Onset Osteoporosis: Rare Monogenic Forms Elucidate the Complexity of Disease Pathogenesis Beyond Type I Collagen.
Costantini A; Mäkitie RE; Hartmann MA; Fratzl-Zelman N; Zillikens MC; Kornak U; Søe K; Mäkitie O
J Bone Miner Res; 2022 Sep; 37(9):1623-1641. PubMed ID: 35949115
[TBL] [Abstract][Full Text] [Related]
18. Airway Resistance Caused by Sphingomyelin Synthase 2 Insufficiency in Response to Cigarette Smoke.
Gupta G; Baumlin N; Poon J; Ahmed B; Chiang YP; Railwah C; Kim MD; Rivas M; Goldenberg H; Elgamal Z; Salathe M; Panwala AA; Dabo A; Huan C; Foronjy R; Jiang XC; Wadgaonkar R; Geraghty P
Am J Respir Cell Mol Biol; 2020 Mar; 62(3):342-353. PubMed ID: 31517509
[TBL] [Abstract][Full Text] [Related]
19. SMS overexpression and knockdown: impact on cellular sphingomyelin and diacylglycerol metabolism, and cell apoptosis.
Ding T; Li Z; Hailemariam T; Mukherjee S; Maxfield FR; Wu MP; Jiang XC
J Lipid Res; 2008 Feb; 49(2):376-85. PubMed ID: 17982138
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of sphingomyelin synthase 1 but not sphingomyelin synthase 2 reduces bone formation due to impaired osteoblast differentiation.
Matsumoto G; Hashizume C; Watanabe K; Taniguchi M; Okazaki T
Mol Med; 2019 Dec; 25(1):56. PubMed ID: 31847800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
